170 related articles for article (PubMed ID: 37491060)
1. [Neuroimaging of Pituitary Neuroendocrine Tumors].
Kurosaki M
No Shinkei Geka; 2023 Jul; 51(4):634-641. PubMed ID: 37491060
[TBL] [Abstract][Full Text] [Related]
2. Up-To-Date Magnetic Resonance Imaging Findings for the Diagnosis of Hypothalamic and Pituitary Tumors.
Kurosaki M; Sakamoto M; Kambe A; Ogura T
Yonago Acta Med; 2021 May; 64(2):155-161. PubMed ID: 34025189
[TBL] [Abstract][Full Text] [Related]
3. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
4. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
5. [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)].
Nagamine T; Fukuda I
No Shinkei Geka; 2023 Jul; 51(4):706-715. PubMed ID: 37491068
[TBL] [Abstract][Full Text] [Related]
6. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
Kara M; Tokat F; Pamir MN; Danyeli AE
Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
9. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
[TBL] [Abstract][Full Text] [Related]
10. Mixed Sparsely Granulated Lactotroph and Densely Granulated Somatotroph Pituitary Neuroendocrine Tumor Expands the Spectrum of Neuroendocrine Neoplasms in Ovarian Teratomas: the Role of Pituitary Neuroendocrine Cell Lineage Biomarkers.
Hodgson A; Pakbaz S; Shenouda C; Francis JA; Mete O
Endocr Pathol; 2020 Sep; 31(3):315-319. PubMed ID: 32632841
[No Abstract] [Full Text] [Related]
11. Application of magnetic resonance 3D-SPACE sequence combined image fusion technique in preoperative evaluation of pituitary macroadenoma.
Nie J; Meng L; Li Z; Zhou G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):980-987. PubMed ID: 33053542
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression and gene expression profiles in corticotroph pituitary neuroendocrine tumor subtypes.
Kiseljak-Vassiliades K; Lipe K; Turin CG; Fishbein L; Costello JC; Kerr JM; Holmstoen TB; Youssef AS; Lillehei KO; Kleinschmidt-DeMasters BK; Wierman ME
J Neuropathol Exp Neurol; 2024 Jun; 83(7):586-595. PubMed ID: 38777808
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of pituitary high-resolution 3D MRI with deep-learning-based reconstruction for perioperative evaluation of pituitary adenomas.
Ishimoto Y; Ide S; Watanabe K; Oyu K; Kasai S; Umemura Y; Sasaki M; Nagaya H; Tatsuo S; Nozaki A; Ikushima Y; Wakayama T; Asano K; Saito A; Tomiyama M; Kakeda S
Neuroradiology; 2024 Jun; 66(6):937-945. PubMed ID: 38374411
[TBL] [Abstract][Full Text] [Related]
15. Is radiomics a useful addition to magnetic resonance imaging in the preoperative classification of PitNETs?
Sathya A ; Goyal-Honavar A; Chacko AG; Jasper A; Chacko G; Devakumar D; Seelam JA; Sasidharan BK; Pavamani SP; Thomas HMT
Acta Neurochir (Wien); 2024 Feb; 166(1):91. PubMed ID: 38376544
[TBL] [Abstract][Full Text] [Related]
16. Multiple tumorous lesions of the pituitary gland.
Schöning JV; Flitsch J; Lüdecke DK; Fahlbusch R; Buchfelder M; Buslei R; Knappe UJ; Bergmann M; Schulz-Schaeffer WJ; Herms J; Glatzel M; Saeger W
Hormones (Athens); 2022 Dec; 21(4):653-663. PubMed ID: 35947342
[TBL] [Abstract][Full Text] [Related]
17. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion.
Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693
[TBL] [Abstract][Full Text] [Related]
18. Pangenomic Classification of Pituitary Neuroendocrine Tumors.
Neou M; Villa C; Armignacco R; Jouinot A; Raffin-Sanson ML; Septier A; Letourneur F; Diry S; Diedisheim M; Izac B; Gaspar C; Perlemoine K; Verjus V; Bernier M; Boulin A; Emile JF; Bertagna X; Jaffrezic F; Laloe D; Baussart B; Bertherat J; Gaillard S; Assié G
Cancer Cell; 2020 Jan; 37(1):123-134.e5. PubMed ID: 31883967
[TBL] [Abstract][Full Text] [Related]
19. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.
Alshaikh OM; Asa SL; Mete O; Ezzat S
Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322
[TBL] [Abstract][Full Text] [Related]
20. [New pathological classification and clinical implications of pituitary neuroendocrine tumors of the 2022 WHO version].
Xie J; Wu ZB
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(47):3723-3726. PubMed ID: 36517420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]